Fernando Andreu

Provides data & analytics of clinical bio specimens

Develops and manufactures drugs and technology for the treatment of cancer

Develops advanced genetic testing technologies

Develops and supplies in vitro diagnostic (IVD) devices

Functions as a College/University

Founded in 2016, Indivumed, Inc. is a precision oncology biotech company dedicated to developing highly specific cancer therapies targeting unmet medical needs, particularly in colorectal cancer and other solid tumors such as non-small cell lung cancer. The company is based in Frederick, MD. The company leverages a proprietary multi-omics and clinical database, IndivuType, derived from standardized tumor samples collected through its clinical network. This platform integrates molecular, biological, technological, and pharmacological data, supported by advanced biomathematical and bioinformatic analyses and patient-derived tumor models, to identify and validate novel therapeutic targets. Indivumed advances both small molecule and biologic drug candidates through discovery, validation, and IND filing stages, and fosters collaboration via its Onco AI-Med network and research partnerships.